These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24612251)

  • 101. How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements.
    Dang HW; Kim SU; Park JY; Ahn SH; Han KH; Chon CY; Park YN; Choi EH; Kim DY
    Yonsei Med J; 2012 Mar; 53(2):337-45. PubMed ID: 22318821
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease.
    Yu H; Huang Y; Li M; Jiang H; Yang B; Xi X; Smayi A; Wu B; Yang Y
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2169-2181. PubMed ID: 38946401
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels.
    Fujiwara A; Sakaguchi K; Fujioka S; Iwasaki Y; Senoh T; Nishimura M; Terao M; Shiratori Y
    J Gastroenterol; 2008; 43(6):484-91. PubMed ID: 18600393
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The diagnostic value of ultrasound elastography in patients with hepatitis B virus infection: a prospective study.
    Gou YZ; Liu B; Jiang W; Yu HT; Bai XF
    J Int Med Res; 2010; 38(6):2117-25. PubMed ID: 21227017
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population.
    Cheng BC; Yen YH; Chen JF; Wu CK; Chang KC; Tseng PL; Tsai MC; Lin MT; Lin JT; Chen JB; Hu TH
    Sci Rep; 2017 Apr; 7():46458. PubMed ID: 28422172
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
    Xiao HM; Shi MJ; Jiang JM; Cai GS; Xie YB; Tian GJ; Xue JD; Mao DW; Li Q; Yang HZ; Guo H; Lei CL; Lu W; Chen L; Liu HB; Wang J; Gao YQ; Chen JZ; Wu SD; Chen HJ; Zhao PT; Zhang CZ; Ou-Yang WW; Wen ZH; Chi XL
    J Ethnopharmacol; 2022 Jul; 293():115210. PubMed ID: 35398501
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.
    Kim SU; Park JY; Kim DY; Ahn SH; Choi EH; Seok JY; Lee JM; Park YN; Chon CY; Han KH
    Hepatol Int; 2010 Aug; 4(4):673-80. PubMed ID: 21286337
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study.
    Sultanik P; Kramer L; Soudan D; Bouam S; Meritet JF; Vallet-Pichard A; Fontaine H; Bousquet L; Boueyre E; Corouge M; Sogni P; Pol S; Mallet V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):505-13. PubMed ID: 27407002
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management.
    Fung J; Lai CL; But D; Wong D; Cheung TK; Yuen MF
    Am J Gastroenterol; 2008 Jun; 103(6):1421-6. PubMed ID: 18422821
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection.
    Xiong M; Li J; Yang S; Zeng F; Ji Y; Liu J; Wu Q; He Q; Jiang R; Zhou F; Wen W; Chen J; Hou J
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00085. PubMed ID: 31651450
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Increased Prevalence of Liver Fibrosis in People Living With Human Immunodeficiency Virus Without Viral Hepatitis Compared to Population Controls.
    Kirkegaard-Klitbo DM; Bendtsen F; Lundgren J; de Knegt RJ; Kofoed KF; Nielsen SD; Benfield T
    J Infect Dis; 2021 Aug; 224(3):443-452. PubMed ID: 33320268
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD.
    Hu D; Wang P; Wang X; Hu X; Huang D; Yan W; Xi D; Han M; Ning Q; Wang H
    J Formos Med Assoc; 2024 Jul; 123(7):773-780. PubMed ID: 38097430
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.
    Yen YH; Chang KC; Tsai MC; Tseng PL; Lin MT; Wu CK; Lin JT; Hu TH; Wang JH; Chen CH
    J Formos Med Assoc; 2018 Apr; 117(4):268-275. PubMed ID: 28947134
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Influence of meal intake on liver stiffness in patients with chronic hepatitis B and C.
    Tangpradabkiet W; Praneenararat S; Chamroonkul N; Witeerungrot T; Piratvisuth T
    J Med Assoc Thai; 2014 Oct; 97(10):1033-9. PubMed ID: 25632619
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study.
    Julián MT; Ballesta S; Pera G; Pérez-Montes de Oca A; Soldevila B; Caballería L; Morillas R; Expósito C; Martínez-Escudé A; Puig-Domingo M; Franch-Nadal J; Torán P; Cusi K; Julve J; Mauricio D; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1051958. PubMed ID: 36714592
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine Aminotransferase.
    Wong RJ; Le A; Nguyen MT; Trinh HN; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Yang J; Garcia RT; Levitt B; da Silveira E; Gish RG
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):146-148. PubMed ID: 28733260
    [No Abstract]   [Full Text] [Related]  

  • 117. Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.
    Druckrey-Fiskaaen KT; Vold JH; Madebo T; Midgard H; Dalgard O; Leiva RA; Fadnes LT;
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):21. PubMed ID: 38532435
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach.
    Huang CY; Lu CW; Liu YL; Chiang CH; Lee LT; Huang KC
    Obesity (Silver Spring); 2016 Feb; 24(2):483-9. PubMed ID: 26719030
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy.
    Yan LB; Zhu X; Bai L; Liang LB; Chen EQ; Du LY; Wang LC; Chen LY; Tang H
    Hepatol Res; 2013 Feb; 43(2):185-91. PubMed ID: 22978384
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B.
    Li J; Gordon SC; Rupp LB; Zhang T; Trudeau S; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Daida YG; Schmidt MA; Lu M;
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1250-1257. PubMed ID: 27888529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.